Acumen Pharmaceuticals, Inc. Stock Issued During Period, Shares, Period Increase (Decrease)
Acumen Pharmaceuticals, Inc. (ABOS) had Stock Issued During Period, Shares, Period Increase (Decrease) of 39.91 million shares as of 2021-07-06, per its 10-Q filed 2022-11-14.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesPeriodIncreaseDecrease · last filed 2022-11-14
- 2021-07-06: Stock Issued During Period, Shares, Period Increase (Decrease) 39.91M shares.
| Period end | Stock Issued During Period, Shares, Period Increase (Decrease) |
|---|---|
| 2021-07-06 | 39.91M shares 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |